Year: 2026

Aktsiaselts Infortar and Nordic Stream Group OÜ signed a share purchase agreement for selling 50% shareholding in the associated company Pakrineeme Sadama OÜ and its subsidiary Balti Gaas OÜ. Following the transaction, Nordic Stream Group OÜ will become the new owner of the 50% shareholding in Pakrineeme Sadama OÜ and 50% belongs to AS Alexela. The transaction is not treated as a transaction beyond everyday economic activities or a transaction of a significant importance, nor as a transaction with related persons, within the meaning of the “Requirements for Issuers” part of the NASDAQ Tallinn Stock Exchange rules. The transaction does not have a significant impact on Aktsiaselts Infortar’s activities. The members of the Supervisory Board and the Management Board of Aktsiaselts Infortar are not personally interested in...

New Location Marks 35th Store in OregonBlack Rock Coffee BarOpening March 31 in BeavertonBlack Rock Coffee BarOpening Soon in BeavertonScottsdale, AZ, March 27, 2026 (GLOBE NEWSWIRE) — Black Rock Coffee Bar, the Oregon-born boutique coffee company known for its specialty coffees, teas, smoothies, and popular Fuel® energy drinks, is growing its footprint in Beaverton with a brand-new location.  Located at 3340 SW Cedar Hills Blvd, the new store will officially open on Tuesday, March 31. Guests are invited to celebrate opening day with an exclusive Black Rock sticker, available with purchase while supplies last. This opening represents the brand’s 35th Oregon location, continuing to deepen its presence in the state where it was founded.  “Oregon has always been a key part of Black Rock’s story, and we’re proud to...

Grand Opening on April 2 Marks 9th Location in IdahoBlack Rock Coffee BarOpening March 31 in Garden CityBlack Rock Coffee BarComing Soon in Garden CityScottsdale, AZ, March 27, 2026 (GLOBE NEWSWIRE) — Black Rock Coffee Bar is bringing its premium roasted coffees, teas, smoothies, and flavorful Fuel energy drinks to a new location in Garden City, opening Thursday, April 2.   The brand’s first Garden City shop, located at 7906 W. Marigold St., Ste 100, will kick off with a full week of promotions to celebrate:  Thursday, April 2: Free 16oz Drinks Friday, April 3: Buy One, Get One Free Drinks Saturday, April 4: 50% Off Food Items Sunday, April 5: Limited Edition Sticker with purchase while supplies last Monday, April 6: Free T-Shirt with purchase while supplies last Tuesday,...

WUHU, China, March 27, 2026 (GLOBE NEWSWIRE) — Chery Group’s new energy vehicle brand iCAUR announced that it will host its iCAUR International Business Summit from April 26 to April 28, 2026, during Auto China 2026, bringing together global partners, media, and industry stakeholders to present the next stage of its new energy strategy. The summit will serve not only as a global partner gathering, but as a platform to demonstrate how iCAUR defines its “new energy gene” — an integrated system that connects design, technology, and real-world application. Reframing New Energy: From Powertrain to SystemAmid continued volatility in global energy markets and the accelerating transition toward electrification, the automotive industry is entering a new phase of reassessment. Increasingly, attention is shifting from how vehicles...

Today, the Tallinn Circuit Court handed down a judgement in the case brought by Tallinn University of Technology against AS Tallinna Vesi, partially upholding Tallinna Vesi’s appeal and partially setting aside the judgement of Harju County Court of 25/04/2025, which had found the claim for late payment interest to be justified prior to 15/07/2022. However, the Tallinn Circuit Court also agreed with the county court that the claim by Tallinn University of Technology against Tallinna Vesi may be justified, at least to some extent; the limitation period should not be applied to the claim, and proceedings should continue regarding the amount of the claim. Tanel Kalaus, Attorney-at-Law and authorised representative of Tallinna Vesi, said: “Today’s judgement contains several positive aspects; for example, the circuit court agreed with our position...

Volta Finance Limited (VTA / VTAS)February 2026 monthly report NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES Guernsey, March 27th, 2026 BNPP AM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for February 2026. The full report is attached to this release and will be available on Volta’s website shortly (www.voltafinance.com). Performance and Portfolio Activity Dear Investors, Volta Finance posted a net return of -3% for the month of February 2026. For comparison, US High Yield bonds returned +0.2%*** and Euro High Yield bonds achieved +0.3%**** over the same period, while the Morningstar Leveraged Loan indices were down -0.8%*** in the US and –0.5%**** in Europe. Although February was initially characterized by President Trump’s announcement...

Poster #76954 highlights QTORIN™ rapamycin’s single phase anhydrous gel formulation designed to optimize dermal bioavailability of rapamycin for mTOR-driven skin diseases while overcoming the crystallization, stability, and dermal penetration challenges posed by rapamycin Poster #76929 highlights a qualitative patient and caregiver interview study evaluating the burden of living with porokeratosis, a serious, rare genetic skin disease characterized by numerous pre-cancerous, pruritic lesions and substantial functional and psychosocial burden WAYNE, Pa., March 27, 2026 (GLOBE NEWSWIRE) — Palvella Therapeutics, Inc., (“Palvella” or “the Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and...

– Improvements seen across all six DLQI Domains indicating broad, beneficial impact on quality of life –– Data further demonstrates first-in-class and best-in-disease barzolvolimab profile – HAMPTON, N.J., March 27, 2026 (GLOBE NEWSWIRE) — Celldex (NASDAQ:CLDX) presented additional positive data from the completed Phase 2 clinical trials of barzolvolimab in chronic spontaneous urticaria (CSU) and cold urticaria (ColdU) and symptomatic dermographism (SD) demonstrating profound improvements in patient quality of life (QoL) across all measured domains: symptoms and feelings, daily activities, leisure, work and school, personal relationships and treatment. Barzolvolimab is a humanized monoclonal antibody with a completely novel mechanism of action that uniquely targets the root cause of CSU, ColdU and SD—the...

SOLANA BEACH, Calif., March 27, 2026 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL) today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 3,188,407 shares of common stock (or pre-funded warrant in lieu thereof) and warrants to purchase up to 6,376,814 shares of common stock, at a combined purchase price of $3.45 per share of common stock (or per pre-funded warrant in lieu thereof) and accompanying warrants, in a private placement priced at-the-market under Nasdaq rules. The warrants will have an exercise price of $3.20 per share, will be exercisable upon issuance and will expire five and one-half years from the Effectiveness Date (as defined below). The private placement is expected to close on or about March 30, 2026, subject to the satisfaction of customary closing...